This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08159/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08159/identifier/pubchem-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08159/identifier/pubchem-substance/
n10http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB08159/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08159/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08159
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB08159 n10:DB08159
dcterms:title
4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE
adms:identifier
n6:4450820 n9:DB08159 n11:99444630 n12:M38 n13:5288720
n3:IUPAC-Name
n4:271B6409-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B640F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B640E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B640B-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B640C-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B640D-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6407-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6405-363D-11E5-9242-09173F13E4C5 n4:271B6408-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6406-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B6415-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6416-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B6410-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B6411-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B6413-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B6412-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6414-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B641B-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B641D-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B641E-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B641A-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6419-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B641C-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B640A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6417-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6418-363D-11E5-9242-09173F13E4C5